Plasma GDF15 levels associated with circulating immune cells predict the efficacy of PD-1/PD-L1 inhibitor treatment and prognosis in patients with advanced non-small cell lung cancer

被引：0
|
作者：
Green Hong
Pureum Sun
Chaeuk Chung
Dongil Park
Song-I Lee
Nayoung Kim
Seong Eun Lee
Jeong Eun Lee
Yea Eun Kang
Da Hyun Kang
机构：
[1] Chungnam National University,Department of Internal Medicine, College of Medicine
[2] Chungnam National University,Institute for Medical Sciences, College of Medicine
来源：
Journal of Cancer Research and Clinical Oncology | 2023年 / 149卷
关键词：
GDF15; Non-small cell lung cancer; Immunotherapy; Survival; Biomarker; Efficacy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：159 / 171
页数：12
相关论文
共 50 条
  • [21] Research progression of PD-1/PD-L1 in non-small cell lung cancer
    Xing Liu
    Xiaodong Xie
    Oncology and Translational Medicine, 2017, 3 (03) : 111 - 115
  • [22] Risk Factors Analysis of AKI in Patients with Primary Non-small Cell Lung Cancer Treated with PD-1/PD-L1 Inhibitor
    Ying, Jiong-Ming
    Yan, Feng
    IRANIAN JOURNAL OF KIDNEY DISEASES, 2024, 18 (02) : 108 - 117
  • [23] Clinical benefit of PD-1/PD-L1 inhibitors for poor performance status patients with advanced non-small cell lung cancer
    Koyama, Junji
    Morise, Masahiro
    Tanaka, Ichidai
    Hori, Sho
    Matsuzawa, Reiko
    Ozone, Sachiko
    Matsushita, Akihiro
    Matsuo, Masaki
    Asano, Shuichi
    Tanaka, Taro
    Shima, Koichiro
    Kimura, Tomoki
    Sakamoto, Koji
    Kondoh, Yasuhiro
    Hashimoto, Naozumi
    JOURNAL OF CHEMOTHERAPY, 2025,
  • [24] Impact of Clinicopathological Features on the Efficacy of PD-1/PD-L1 Inhibitors in Patients with Previously Treated Non-Small Cell Lung Cancer
    Jiang, T.
    Qiao, M.
    Zhou, C.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2419 - S2419
  • [25] PD-L1 expression in circulating tumor cells of advanced non-small cell lung cancer patients treated with nivolumab
    Guibert, Nicolas
    Delaunay, Myriam
    Lusque, Annelle
    Boubekeur, Nadia
    Rouquette, Isabelle
    Clermont, Estelle
    Mourlanette, Jean
    Gouin, Sandrine
    Dormoy, Inge
    Favre, Gilles
    Mazieres, Julien
    Pradines, Anne
    LUNG CANCER, 2018, 120 : 108 - 112
  • [26] Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
    Patil, Namrata S.
    Nabet, Barzin Y.
    Mueller, Soeren
    Koeppen, Hartmut
    Zou, Wei
    Giltnane, Jennifer
    Au-Yeung, Amelia
    Srivats, Shyam
    Cheng, Jason H.
    Takahashi, Chikara
    de Almeida, Patricia E.
    Chitre, Avantika S.
    Grogan, Jane L.
    Rangell, Linda
    Jayakar, Sangeeta
    Peterson, Maureen
    Hsia, Allison W.
    O'Gorman, William E.
    Ballinger, Marcus
    Banchereau, Romain
    Shames, David S.
    CANCER CELL, 2022, 40 (03) : 289 - +
  • [27] Antibiotics are associated with attenuated efficacy of anti-PD-1/PD-L1 therapies in Chinese patients with advanced non-small cell lung cancer
    Zhao, Sha
    Gao, Guanghui
    Li, Wei
    Li, Xuefei
    Zhao, Chao
    Jiang, Tao
    Jia, Yijun
    He, Yayi
    Li, Aiwu
    Su, Chunxia
    Ren, Shengxiang
    Chen, Xiaoxia
    Zhou, Caicun
    LUNG CANCER, 2019, 130 : 10 - 17
  • [28] PD-1 and PD-L1 as immunotherapy targets and biomarkers in non-small cell lung cancer
    Tsoukalas, Nikolaos
    Kiakou, Maria
    Tsapakidis, Konstantinos
    Tolia, Maria
    Aravantinou-Fatorou, Eleni
    Baxevanos, Panagiotis
    Kyrgias, Georgios
    Theocharis, Stamatios
    JOURNAL OF BUON, 2019, 24 (03): : 883 - 888
  • [29] Efficacy of combined PD-1 immune therapy and chemotherapy in the treatment of locally advanced non-small cell lung cancer
    Li, Yongjie
    Fu, Dunzhi
    Li, Biao
    Zhou, Yuan
    Li, Fan
    Wang, Qiongyu
    Huang, Jialei
    TROPICAL JOURNAL OF PHARMACEUTICAL RESEARCH, 2023, 22 (05) : 1065 - 1071
  • [30] Pharmacodynamics of current and emerging PD-1 and PD-L1 inhibitors for the treatment of non-small cell lung cancer
    Rocco, Danilo
    Malapelle, Umberto
    Del Re, Marzia
    Della Gravara, Luigi
    Pepe, Francesco
    Danesi, Romano
    Troncone, Giancarlo
    Gridelli, Cesare
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2020, 16 (02) : 87 - 96
12345